HDMA ANNOUNCES NEW
EXECUTIVE COMMITTEE AND BOARD OF DIRECTORS

Arlington, VA – June 2, 2009 – At its Executive Committee and Board of Directors meeting on May 12, the Healthcare Distribution Management Association (HDMA) announced the members of its expanded Executive Committee and Board of Directors. New by-laws passed at its previous Board Meeting in November, 2008 increased the size of the HDMA Board of Directors from its past structure of 13 Active distributor members to one representative (or corporate officer) from each Active member company and extended its Executive Committee membership from six to seven Active members.

“I look forward to working with this talented new slate of Executive Committee and Board of Director members,” said HDMA President and CEO John M. Gray. “The inclusive nature of the new Board will enable all HDMA Active members to be even more fully engaged in critical issues affecting the healthcare distribution industry. I am confident that together we will continue to make substantial progress in increasing patient safety, enhancing efficiency and adding business value.”

Members of the HDMA Executive Committee, comprised of HDMA’s Officers, include:

• Chairman, Paul Julian, Executive Vice President & Group President, McKesson Corporation; 
• Vice Chairman, David Moody, Chief Executive Officer, N.C. Mutual Wholesale Drug Co.;
• Steven Collis, President, AmerisourceBergen Specialty Group;
• Ken  Couch, President, Smith Drug Company;
• John Gray, President and CEO, HDMA;
• Michael  Kaufmann, President, Healthcare Supply Chain Services – Pharmaceutical, Cardinal Health, Inc.;
• Christopher  Mitiguy, Vice President, Burlington Drug Company, Inc.; and
• Ted Scherr, President and Chief Executive Officer, Dakota Drug, Inc., newly elected to the Executive Committee.

Members of the expanded Board of Directors include HDMA’s Executive Committee members and the following directors:

• Dawn Boyter, Chief Executive Officer, Richie Pharmacal Co., LLC;
• Bruce Broussard, President, US Oncology;
• Larry Doud, Chief Executive Officer, Rochester Drug Company;
• Greg Duche, Chief Executive Officer, R&S Northeast, LLC;
• Dennis Engel, Chief Executive Officer, KeySource Medical, Inc.;
• Richard Gaton, President, BDI Pharma, Inc.;
• Sam Lazich, President, DMS Pharmaceutical Group, Inc.;
• John Letizia, Chairman, President & CEO, Value Drug Company;
• Jay Levine, President & Chief Operating Officer, Harvard Drug Group;
• Albert Paonessa, III, Executive Vice President & COO, Anda, Inc.;
• Gary Prester, Vice President, Marketing, Dik Drug Co.;
• Anthony Rattini, President, Miami-Luken, Inc.;
• John Ray, President & CEO, Top Rx;
• George Richards, President, Capital Wholesale Drug Co.;
• Raul Rodriguez-Font, President, Drogueria Betances, Inc.;
• John Sasen, EVP and Chief Marketing Officer, PSS World Medical, Inc.;
• Christopher Schoen, Vice President, Sales, Prescription Supply, Inc.;
• Robert Schwartz, Chief Operating Officer, Southwood Pharmaceuticals, Inc.;
• Joseph Shoneff, Executive Vice President, Valley Wholesale Drug Company;
• J. Christopher Smith, President & Chief Operating Officer, H.D. Smith; and
• Sonia Thuna, President, FMC Distributors.

About HDMA
The Healthcare Distribution Management Association (HDMA) is the national association representing primary, full-service healthcare distributors. Each business day, the member companies of HDMA are responsible for ensuring that more than eight million prescription medicines and healthcare products are safely delivered to 145,000 pharmacies, hospitals, nursing homes, physician offices, clinics, government and other providers in all 50 states. This essential public health function is provided with tremendous efficiency, saving the nation’s healthcare system nearly $32 billion each year. HDMA and its members are the vital link in the healthcare system, working daily to provide value, remove costs and develop innovative solutions to deliver care safely and effectively.